|
The Institutional Review Board: A Road Map and Why You Want to Go There Presented by: Sara H. Kiskaddon, J.D. The IRB exists as a federally mandated board in all institutions engaged in human research. Its purpose is to assure in advance and by periodic review, that appropriate steps are taken to protect the rights and welfare of all participants in involved in research. (Research is defined as any systematic analysis designed to obtain generalizable knowledge with data linked to a person.) The IRB is composed of at least 5 members of diverse backgrounds with at least: 1 scientist, 1 non-scientist, and 1 person non-affiliated with the institution. CCMC has 12 members (see link). Applications - 15 copies must be signed the PI (principle investigator) and delivered 3 weeks before the meeting date (each 2nd Monday of the month). Each is assigned a primary and secondary reviewer. Reviews are stratified as:
The IRB keeps minutes (CCMC staff can access the minutes through the g drive: ccmcdocs/res/IRBadmin/minutes) and has the authority to approve, approve with contingencies, and table / disapprove protocols. A response is provided to the PI one week after a meeting. The Informed Consent:
The IRB process seeks to ensure the principles of Beneficence, Justice, and Autonomy for research participants as outlined by a National Commission.
Many controversies currently exist in the arena of clinical research. New regulations concerning outcomes research will impact upon all phases of the process. The HIPAA regulations are soon to be fully implemented (Health Insurance Portability and Accountability Act of 1996). Summarized by F. DiMario |
| Copyright © 2009, CCMC, All rights Reserved. Disclaimers | |
| Research at Connecticut Children's | ||
| Resources for Investigators | ||
| Institutional Review Board | ||
| Centers & Investigators | ||
| Clinical Trials Unit | ||
| Child Health Data Center | ||
| Resources for Families | ||
| Support Connecticut Children's Research | ||
| Contacts | ||